Molecular Partners Ag (MOLN) Liabilities and Shareholders Equity (2021 - 2025)
Historic Liabilities and Shareholders Equity for Molecular Partners Ag (MOLN) over the last 6 years, with Q3 2025 value amounting to $140195.8.
- Molecular Partners Ag's Liabilities and Shareholders Equity fell 2123.45% to $140195.8 in Q3 2025 from the same period last year, while for Sep 2025 it was $628177.0, marking a year-over-year increase of 223.61%. This contributed to the annual value of $180199.0 for FY2024, which is 1941.48% down from last year.
- According to the latest figures from Q3 2025, Molecular Partners Ag's Liabilities and Shareholders Equity is $140195.8, which was down 2123.45% from $150082.8 recorded in Q2 2025.
- In the past 5 years, Molecular Partners Ag's Liabilities and Shareholders Equity ranged from a high of $337665.2 in Q1 2022 and a low of $188.67 during Q2 2024
- Over the past 5 years, Molecular Partners Ag's median Liabilities and Shareholders Equity value was $184111.0 (recorded in 2021), while the average stood at $177674.5.
- In the last 5 years, Molecular Partners Ag's Liabilities and Shareholders Equity tumbled by 9990.97% in 2021 and then soared by 7944896.58% in 2025.
- Quarter analysis of 5 years shows Molecular Partners Ag's Liabilities and Shareholders Equity stood at $187258.8 in 2021, then skyrocketed by 45.38% to $272229.5 in 2022, then dropped by 17.86% to $223613.0 in 2023, then decreased by 19.07% to $180963.2 in 2024, then dropped by 22.53% to $140195.8 in 2025.
- Its Liabilities and Shareholders Equity stands at $140195.8 for Q3 2025, versus $150082.8 for Q2 2025 and $156935.2 for Q1 2025.